People on the Move
J Donald deBethizy
Clinical-stage biopharmaceutical firm Santaris Pharma has hired J Donald deBethizy as president and CEO.
DeBethizy said he was excited to join Santaris’ work on RNA-targeted therapies.
"Since its founding in Denmark in 2003, Santaris has built a strong R&D team who has made great strides at developing a deep pipeline of preclinical and clinical stage RNA therapeutics and a significant patent estate.
“Importantly, the company has demonstrated in phase 2 clinical trials that the LNA platform can deliver potent and safe oligonucleotide compounds which treat disease.
“I am confident that the company will bring additional LNA-drugs against disease relevant mRNAs and microRNAs into the clinic in the near term."
Vacating his two-year position as Santaris’s CEO is Henrik Stage, who will remain at the company as CFO and Executive VP of Corporate Development.
